ReliaTech GmbH

What ReliaTech GmbH does

ReliaTech GmbH is a German biotechnology company founded in 1999 and headquartered in Wolfenbüttel, Germany, that develops, produces, and distributes research-grade recombinant proteins, antibodies, and soluble receptors. The company serves academic research institutions, biotechnology and pharmaceutical firms, and contract research organizations (CROs) across global markets including Europe, the USA, Japan, China, Australia, and Korea. ReliaTech operates under Managing Director Dr. Markus Heine as a privately held GmbH with a small team of approximately 8 employees.

The company's core technical capabilities center on recombinant protein expression using three production platforms — E. coli, insect cells, and CHO (Chinese Hamster Ovary) cells — enabling it to produce proteins with diverse folding and post-translational modification requirements. Its catalog exceeds 925 products spanning recombinant proteins (654), antibodies (273), soluble receptors (59), supplements, and lysates, with stated specialization in cytokines and growth factors — a domain requiring deep expertise in protein folding, purification, and bioactivity validation.

ReliaTech operates a hybrid commercial model combining direct e-commerce sales of catalog reagents with sales-led contract manufacturing services for custom protein and antibody production. Per-unit pricing ranges from approximately €70 to €714, indicative of small-order transactional sales typical of academic and early-stage research buyers. International distribution is supported by a Partner & Distributors network that extends the company's commercial reach well beyond its in-house headcount, and a current 'New Products' section (including Human holo-Transferrin, Animal free) signals ongoing catalog refresh activity.

Name

ReliaTech GmbH

Legal name

ReliaTech GmbH

Website

https://reliatech.de

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

ReliaTech GmbH is a German biotechnology company founded in 1999 that produces and distributes recombinant proteins, antibodies, and soluble receptors for academic research institutions, biotechnology and pharmaceutical companies, and CROs across global markets.

Ownership category

akta.pro rank

Product category

Life Science Research Reagents

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Biological Products, (No Disgnostic Substances) (2836), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

Keywords

• Recombinant proteins
• Research antibodies
• Cytokines growth factors
• Contract protein production
• Life science reagents

Headquarters

HQ city

Wolfenbüttel

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Research Reagent Sales: Sale of recombinant proteins, antibodies (monoclonal and polyclonal), and specialty products for research purposes. Products sold in various sizes with per-unit pricing.
2. Contract Manufacturing Services: Custom protein and antibody production services including protein production in E. coli, insect cells, and custom antibody generation. Billed per project or service engagement.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

ReliaTech manufactures and sells premium research reagents including recombinant proteins (cytokines, growth factors, soluble receptors), monoclonal and polyclonal antibodies, and specialty products such as supplements and lysates for life science research. Alongside its catalog of 925+ validated products, the company provides contract manufacturing services covering custom protein production in E. coli and insect cell systems, IXpress-based polyclonal antibody generation, and custom reagent formulation to customer specifications.

Product overview

ReliaTech GmbH is a premium research reagent and antibody provider operating a unified catalog + custom contract services platform. The product portfolio consists of three core reagent product lines—Recombinant Proteins (encompassing Cytokines & Growth Factors and Soluble Receptors sub-categories), Antibodies (split into Polyclonal and Monoclonal sub-categories), and Specialities (including Supplements and Lysates). These catalog products are complemented by Contract Work Services, which include Protein Production in E. coli, Protein Production in Insect Cells, IXpress & Polyclonal Antibody services, and Reagent Formulation services. The company serves research institutions and biotech companies requiring high-quality proteins and antibodies for life science research, with products available in multiple sizes and configurations.

Differentiator

Problem solved

Functional benefit

Products and services

• Recombinant Proteins

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Partner & Distributors NetworkminorChannel Partner/ Reseller/ DistributorReliaTech maintains a network of partners and distributors for their research reagents. The company has a dedicated 'Partner & Distributors' page on their website indicating distribution partnerships to extend market reach globally.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• ACRO Biosystems: Specialized manufacturer of recombinant proteins including cytokines, growth factors, and Fc receptors for research and biologics drug development. Closely comparable niche focus on high-quality recombinant proteins and similar target buyers in biotech and pharma.
• GenScript: Global biotech offering recombinant protein expression services and catalog proteins/antibodies, with custom gene-to-protein workflows. Highly comparable to ReliaTech in combining catalog recombinant proteins and contract protein production services, but operating at significantly greater scale.
• ProSpec-Tany TechnoGene: Israel-based recombinant protein manufacturer specializing in cytokines, growth factors, and antigens for research use. Closely comparable niche focus on premium recombinant proteins for academic and biotech research customers.
• Sino Biological: China-based reagent provider offering recombinant proteins, antibodies, and CRO services for research and drug discovery. Directly comparable product portfolio (recombinant proteins, mAbs/pAbs, contract services) and competes head-to-head in the same target customer segments.
• PeproTech (a Bio-Techne brand): Now part of Bio-Techne, historically specialized in recombinant cytokines and growth factors for life science research. Direct historical competitor to ReliaTech in the cytokine/growth factor reagent segment.

Broad incumbents

• Abcam: Major antibody reagent supplier (now part of Danaher) with extensive catalog of monoclonal and polyclonal antibodies. Competes with ReliaTech's antibody product line and benefits from larger validation programs and global distribution.
• Miltenyi Biotec: Germany-based life sciences company with strong catalogs in cytokines, antibodies, and cell culture reagents. Comparable to ReliaTech in offering recombinant proteins and antibodies for academic and biotech customers, but at much larger scale and with broader cell therapy instruments.
• Bio-Techne: Major life science tools company that acquired both R&D Systems and PeproTech, offering extensive catalogs of recombinant proteins, cytokines, growth factors, and antibodies. Directly competes with ReliaTech across nearly all core product lines but with vastly larger scale, IP, and global sales coverage.

Emerging players

• CellGenix: Supplier of cytokines, growth factors, and cell culture reagents for cell and gene therapy applications. Comparable to ReliaTech in recombinant protein offerings, with overlapping academic and biotech customers.

Regional players

• STEMCELL Technologies: Canada-based supplier of cell culture media, supplements, cytokines, and specialized reagents for stem cell and immunology research. Overlaps with ReliaTech in cytokines, supplements, and lysates, though with stronger positioning in cell culture workflows.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/reliatech-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ReliaTech GmbH